|
Malignant Head and Neck Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
<sup>18</sup> F-FDG PET/CT for locoregional surveillance following definitive treatment of head and neck cancer: A meta-analysis of reported studies.
|
30456825 |
2019 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
We conducted a prospective, pilot study of carotid artery inflammation using <sup>18</sup>F-labeled 2-fluoro-2-deoxy-d-glucose ([<sup>18</sup>F]FDG) PET/CT imaging pre- and 3 months post-RT in head-and-neck cancer (HNC) patients.
|
31109689 |
2019 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
Voxel based comparison and texture analysis of 18F-FDG and 18F-FMISO PET of patients with head-and-neck cancer.
|
30818360 |
2019 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
Incidental findings on 18-FDG PET-CT in head and neck cancer. A retrospective case-control study of incidental findings on 18-FDG PET-CT in patients with head and neck cancer.
|
30535976 |
2019 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
Inter-observer and segmentation method variability of textural analysis in pre-therapeutic FDG PET/CT in head and neck cancer.
|
30921388 |
2019 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Prognostic value of 18F-FDG PET/CT functional parameters in patients with head and neck cancer: a meta-analysis.
|
30664599 |
2019 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
Associations between FDG-PET and Ki 67-index in head and neck cancer: A meta-analysis.
|
31577779 |
2019 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
Sequential delayed <sup>18</sup>F-FDG PET/CT examinations may increase specificity of this scan and provide information for the differentiation benign and malignant lymph nodes in the cases of head and neck cancer.
|
29324917 |
2019 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A radiomics signature built from <sup>18</sup>F-FDG PET and contrast-enhanced CT features correlates with <sup>18</sup>F-FMISO TBR<sub>max</sub> in head and neck cancer patients, providing significantly better performance with respect to models based on <sup>18</sup>F-FDG PET only.
|
29273260 |
2018 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer.
|
28940101 |
2018 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
Radiomic Profiling of Head and Neck Cancer: <sup>18</sup>F-FDG PET Texture Analysis as Predictor of Patient Survival.
|
30363632 |
2018 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
Use of baseline 18F-FDG PET scan to identify initial sub-volumes with local failure after concomitant radio-chemotherapy in head and neck cancer.
|
29774104 |
2018 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
This study illustrates how the incidental findings discovered on FDG PET/CT frequently necessitate additional evaluations unrelated to the index head and neck cancer.
|
29160180 |
2018 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.
|
30394934 |
2018 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
The utility of fluorodeoxyglucose positron emission tomography (FDG-PET) imaging to predict outcome has been well-established for patients undergoing definitive radiation in the initial management of head and neck cancer.
|
29573279 |
2018 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
Correction to: FDG uptake in cervical lymph nodes in children without head and neck cancer.
|
29234851 |
2018 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
FDG uptake in cervical lymph nodes in children without head and neck cancer.
|
28357549 |
2017 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
<sup>18</sup>F-FDG PET/CT images from patients with HNC who previously underwent RT were retrospectively reviewed.
|
28697190 |
2017 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
Role of FDG PET/CT Scan in Head and Neck Cancer Patients.
|
28745907 |
2017 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
18F-FDG-PET/CT for the detection of disease in patients with head and neck cancer treated with radiotherapy.
|
28771540 |
2017 |
|
Malignant Head and Neck Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
<sup>18</sup>F-FDG PET/CT surveillance for the detection of recurrence in patients with head and neck cancer.
|
28027517 |
2017 |